Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 27: 612-614, 1981;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McBride, J. H.
Right arrow Articles by Davies, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McBride, J. H.
Right arrow Articles by Davies, R. J.

Clinical Chemistry, Vol 27, 612-614, Copyright © 1981 by American Association for Clinical Chemistry

Adsorbent treatment and immunoaffinity chromatography compared for removing estradiol-17 beta from plasma

JH McBride and RJ Davies

Removal of estradiol-17 beta from plasma by immunoaffinity chromatography on anti-estradiol antibodies coupled to Sepharose was investigated and compared with the use of charcoal adsorbent. Both methods completely removed added [3H]estradiol from pooled male plasma. In contrast to the adsorbent treatment, which caused marked changes in the biochemical composition of the plasma, immunoaffinity chromatography caused only minor perturbations. We discuss the advantages of using plasma, stripped of endogenous estradiol or other steroids by immunoaffinity chromatography, in construction of radioimmunoassay calibration curves.


The following articles in journals at HighWire Press have cited this article:


Home page
 Cancer Res.Home page
L. Zhang and G. J. Barritt
Evidence that TRPM8 Is an Androgen-Dependent Ca2+ Channel Required for the Survival of Prostate Cancer Cells
Cancer Res., November 15, 2004; 64(22): 8365 - 8373.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Association for Clinical Chemistry.